TY  - GEN
AU  - Péron,J M
AU  - Bureau,C
AU  - Gourdy,P
AU  - Lulka,H
AU  - Souque,A
AU  - Calippe,B
AU  - Selves,J
AU  - Al Saati,T
AU  - Bernad,J
AU  - Cordelier,P
AU  - Couderc,B
AU  - Pradayrol,L
AU  - Pipy,B
AU  - Buscail,L
AU  - Vinel,J P
TI  - Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity
SN  - 0017-5749
PY  - 2007///0201
KW  - Animals
KW  - Antineoplastic Agents
KW  - immunology
KW  - Cell Division
KW  - Cell Line, Tumor
KW  - Disease Models, Animal
KW  - Female
KW  - Fibroblasts
KW  - Flow Cytometry
KW  - methods
KW  - Genetic Therapy
KW  - Immunity, Innate
KW  - Immunohistochemistry
KW  - Injections, Intraperitoneal
KW  - Interleukin-12
KW  - administration & dosage
KW  - Macrophages
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Nitric Oxide
KW  - biosynthesis
KW  - Pancreatic Neoplasms
KW  - genetics
KW  - Peritoneal Neoplasms
KW  - Reactive Oxygen Species
KW  - metabolism
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/gut.2005.083477
ER  -